Published Guidance, NICE advice and quality standards

Skip to filters Skip to results

Showing 671 to 680 of 700

Sort by

Last updated date between 1/4/2018 and 28/3/2024Remove Last updated date between 1/4/2018 and 28/3/2024 filter
Type: GuidanceRemove Type: Guidance filter
Type: Quality standardRemove Type: Quality standard filter
Guidance programme: Technology appraisal guidanceRemove Guidance programme: Technology appraisal guidance filter
Guidance programme: Clinical guidelinesRemove Guidance programme: Clinical guidelines filter
Guidance programme: Medical technologies guidanceRemove Guidance programme: Medical technologies guidance filter
Guidance programme: Diagnostics guidanceRemove Guidance programme: Diagnostics guidance filter
Guidance programme: Highly specialised technologies guidanceRemove Guidance programme: Highly specialised technologies guidance filter
Guidance programme: Social care guidelinesRemove Guidance programme: Social care guidelines filter
Guidance programme: Antimicrobial prescribing guidelinesRemove Guidance programme: Antimicrobial prescribing guidelines filter
Guidance programme: Public health guidelinesRemove Guidance programme: Public health guidelines filter
Guidance programme: Cancer service guidelinesRemove Guidance programme: Cancer service guidelines filter
Guidance programme: Medicines practice guidelinesRemove Guidance programme: Medicines practice guidelines filter
Guidance programme: Safe staffing guidelinesRemove Guidance programme: Safe staffing guidelines filter

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
E‑vita open plus for treating complex aneurysms and dissections of the thoracic aorta	MTG16	18 December 2013	1 October 2018
Inotuzumab ozogamicin for treating relapsed or refractory B-cell acute lymphoblastic leukaemia	TA541	19 September 2018	19 September 2018
Chronic heart failure in adults: diagnosis and management	NG106	12 September 2018	12 September 2018
Preventing suicide in community and custodial settings	NG105	10 September 2018	10 September 2018
Lutetium (177Lu) oxodotreotide for treating unresectable or metastatic neuroendocrine tumours	TA539	29 August 2018	29 August 2018
Flu vaccination: increasing uptake	NG103	22 August 2018	22 August 2018
Dinutuximab beta for treating neuroblastoma	TA538	22 August 2018	22 August 2018
Lenvatinib and sorafenib for treating differentiated thyroid cancer after radioactive iodine	TA535	8 August 2018	8 August 2018
Alectinib for untreated ALK-positive advanced non-small-cell lung cancer	TA536	8 August 2018	8 August 2018
Ixekizumab for treating active psoriatic arthritis after inadequate response to DMARDs	TA537	8 August 2018	8 August 2018

Results per page

10
25
50
All